De O. Garcia

Barretos, SP, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Genomic landscape of pediatric germ cell tumors reveals oncogenic mutations and copy number alterations.

Genomic landscape of pediatric germ cell tumors reveals oncogenic mutations and copy number alterations.

Journal: Frontiers in oncology
Published: August 19, 2025

Functional pri-miR-34b/c rs4938723 and KRAS 3'UTR rs61764370 SNPs: Novel phenotype modifiers in Li-Fraumeni Syndrome?

Functional pri-miR-34b/c rs4938723 and KRAS 3'UTR rs61764370 SNPs: Novel phenotype modifiers in Li-Fraumeni Syndrome?

Journal: Gene
Published: July 25, 2023

High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population.

High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population.

Journal: Frontiers in oncology
Published: June 13, 2023

Genomic profile of two Brazilian choroid plexus tumors by whole-exome sequencing.

Genomic profile of two Brazilian choroid plexus tumors by whole-exome sequencing.

Journal: Cold Spring Harbor molecular case studies
Published: September 23, 2022

Insights on variant analysis in silico tools for pathogenicity prediction.

Insights on variant analysis in silico tools for pathogenicity prediction.

Journal: Frontiers in genetics
Published: August 02, 2022

Whole-Exome Sequencing Identifies Pathogenic Germline Variants in Patients with Lynch-Like Syndrome.

Whole-Exome Sequencing Identifies Pathogenic Germline Variants in Patients with Lynch-Like Syndrome.

Journal: Cancers
Published: April 13, 2022

New insights on familial colorectal cancer type X syndrome.

New insights on familial colorectal cancer type X syndrome.

Journal: Scientific reports
Published: June 29, 2021

Using Co-segregation and Loss of Heterozygosity Analysis to Define the Pathogenicity of Unclassified Variants in Hereditary Breast Cancer Patients.

Using Co-segregation and Loss of Heterozygosity Analysis to Define the Pathogenicity of Unclassified Variants in Hereditary Breast Cancer Patients.

Journal: Frontiers in oncology
Published: June 10, 2020
Showing 1-8 of 8

Last Updated: 09/26/2026